Cardinal Health, Inc. (NYSE:CAH) was the recipient of a large growth in short interest during the month of June. As of June 30th, there was short interest totalling 10,498,346 shares, a growth of 55.4% from the June 15th total of 6,756,952 shares. Based on an average daily volume of 2,700,926 shares, the days-to-cover ratio is currently 3.9 days. Approximately 3.3% of the company’s stock are short sold.

In related news, CEO of Cardinal Health’s pharmaceutical segment Jon L. Giacomin sold 23,270 shares of the company’s stock in a transaction on Friday, May 12th. The stock was sold at an average price of $72.87, for a total transaction of $1,695,684.90. Following the completion of the sale, the insider now directly owns 55,440 shares in the company, valued at approximately $4,039,912.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 0.94% of the company’s stock.

A number of hedge funds have recently made changes to their positions in the company. Alpha Windward LLC increased its stake in shares of Cardinal Health by 0.7% in the second quarter. Alpha Windward LLC now owns 2,299 shares of the company’s stock worth $179,000 after buying an additional 17 shares during the period. HL Financial Services LLC increased its stake in shares of Cardinal Health by 0.3% in the first quarter. HL Financial Services LLC now owns 11,887 shares of the company’s stock worth $969,000 after buying an additional 38 shares during the period. Edmond DE Rothschild Holding S.A. increased its stake in shares of Cardinal Health by 0.9% in the first quarter. Edmond DE Rothschild Holding S.A. now owns 4,321 shares of the company’s stock worth $353,000 after buying an additional 39 shares during the period. Private Trust Co. NA increased its stake in shares of Cardinal Health by 0.3% in the first quarter. Private Trust Co. NA now owns 13,731 shares of the company’s stock worth $1,119,000 after buying an additional 41 shares during the period. Finally, Honkamp Krueger Financial Services Inc. increased its stake in shares of Cardinal Health by 1.3% in the first quarter. Honkamp Krueger Financial Services Inc. now owns 4,575 shares of the company’s stock worth $373,000 after buying an additional 60 shares during the period. 87.52% of the stock is owned by institutional investors.

Cardinal Health (NYSE:CAH) opened at 77.32 on Friday. The firm has a market capitalization of $24.42 billion, a price-to-earnings ratio of 18.46 and a beta of 0.81. The company’s 50-day moving average price is $76.76 and its 200 day moving average price is $77.11. Cardinal Health has a 12 month low of $62.70 and a 12 month high of $85.52.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Monday, May 1st. The company reported $1.53 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.46 by $0.07. The company had revenue of $31.82 billion during the quarter, compared to the consensus estimate of $32.30 billion. Cardinal Health had a return on equity of 25.78% and a net margin of 1.05%. Cardinal Health’s revenue for the quarter was up 3.8% on a year-over-year basis. During the same period in the previous year, the business earned $1.43 EPS. Analysts predict that Cardinal Health will post $5.35 EPS for the current year.

The firm also recently declared a quarterly dividend, which was paid on Saturday, July 15th. Shareholders of record on Monday, July 3rd were issued a dividend of $0.4624 per share. This represents a $1.85 dividend on an annualized basis and a yield of 2.39%. This is an increase from Cardinal Health’s previous quarterly dividend of $0.45. The ex-dividend date of this dividend was Thursday, June 29th. Cardinal Health’s payout ratio is 44.05%.

A number of brokerages recently weighed in on CAH. Needham & Company LLC began coverage on Cardinal Health in a research note on Tuesday, April 4th. They set a “hold” rating for the company. Evercore ISI upgraded Cardinal Health to an “outperform” rating in a research note on Thursday, April 6th. Zacks Investment Research cut Cardinal Health from a “hold” rating to a “sell” rating in a research note on Tuesday, July 4th. Credit Suisse Group restated an “outperform” rating and set a $87.00 price objective (up from $81.00) on shares of Cardinal Health in a research note on Thursday, July 13th. Finally, BidaskClub cut Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, July 11th. One analyst has rated the stock with a sell rating, sixteen have given a hold rating and five have assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and an average price target of $82.99.

ILLEGAL ACTIVITY WARNING: This news story was reported by Daily Political and is the sole property of of Daily Political. If you are viewing this news story on another site, it was illegally copied and reposted in violation of U.S. and international trademark and copyright legislation. The correct version of this news story can be accessed at https://www.dailypolitical.com/2017/07/21/cardinal-health-inc-nysecah-short-interest-update.html.

Cardinal Health Company Profile

Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.

Receive News & Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.